Solid Biosciences Inc. (SLDB) Share-based Payment Arrangement, Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Solid Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.61 M, a 23.9% decline year-over-year.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $7.12 M, a 1.07% increase year-over-year.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.63 M, a 1.17% increase from 2022.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.54 M, a 43.6% decline from 2021.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.4 M, a 15% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.12 M $1.61 M -$507 K -23.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $7.63 M $1.94 M +$351 K +22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $7.27 M $1.63 M +$101 K +6.63% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $7.17 M $1.94 M +$130 K +7.17% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.04 M $2.12 M -$494 K -18.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $7.54 M $1.59 M -$1.83 M -53.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $9.37 M $1.52 M -$1.89 M -55.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $11.3 M $1.81 M -$1.82 M -50.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $13.1 M $2.61 M -$295 K -10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $13.4 M $3.42 M +$897 K +35.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $12.5 M $3.42 M +$652 K +23.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $11.8 M $3.64 M +$392 K +12.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $11.4 M $2.91 M -$197 K -6.35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $11.6 M $2.52 M -$886 K -26% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $12.5 M $2.76 M -$628 K -18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $13.1 M $3.24 M -$668 K -17.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $13.8 M $3.1 M -$396 K -11.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $14.2 M $3.4 M +$1.37 M +67.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $12.8 M $3.39 M +$1.6 M +88.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $11.2 M $3.91 M +$2.6 M +199% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $8.64 M $3.5 M +$2.68 M +327% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $5.96 M $2.03 M +$1.21 M +147% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $4.75 M $1.8 M +$1.01 M +127% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $3.74 M $1.31 M +$822 K +169% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $2.92 M $819 K -$2.41 M -74.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $5.33 M $823 K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $790 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $487 K Mar 30, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $3.23 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.